AK105 and anlotinib

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

AK105 and anlotinib
Treatment and conditionWhere it standsTrials
AK105 and anlotinib for uterine cervical neoplasmsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1